Spac Disclosure: What Must Be Filed and What Goes Wrong

A SPAC's IPO requires filing a registration statement on Form S-1 that discloses the SPAC's investment strategy, the identity and qualifications of the management team and sponsors, the terms of the founder share arrangement, and all material conflicts of interest. Risk factors must disclose all material risks investors would consider important, including the risk that the SPAC may not identify a suitable acquisition target and the risk of significant post-merger stock price decline. Generic or boilerplate risk factor disclosures do not satisfy the SEC's disclosure standards and are a frequent target of SEC comment letters. SPACs preparing to file an S-1 registration statement should engage SEC compliance counsel to review all disclosures for accuracy, completeness, and compliance with the SEC's disclosure requirements.

SPAC sponsors occupy a structurally conflicted position in every de-SPAC transaction. The sponsor's founder shares, typically representing 20 percent of the SPAC's post-IPO equity, are acquired at a nominal price and create a financial incentive to complete a merger even on terms that may not serve public shareholders' best interests. The full economic terms of the sponsor's promote, the number of founder shares, the price paid, the dilutive effect on public shareholders, and the vesting conditions, must be fully disclosed in both the S-1 and the de-SPAC proxy statement. SPAC sponsors who are uncertain about the adequacy of their compensation and conflict disclosures should immediately engage disclosure statements counsel to review all transaction-related disclosure obligations before filing.

Required disclosures include audited financial statements for the target company, the financial analysis underlying the fairness opinion, and the negotiation history of the merger. All material conflicts of interest between the SPAC sponsor and the target company, and the basis for the financial projections presented to investors, must also be disclosed. The SEC has been highly active in issuing comment letters on de-SPAC proxy statements, focusing on the adequacy of conflict disclosures, the basis for financial projections, and the disclosure of compensation arrangements. SPACs preparing a proxy statement or S-4 for a pending de-SPAC merger should engage SEC regulations counsel to respond to SEC comments and ensure the disclosure satisfies current enforcement priorities.

SPAC targets frequently present five-year revenue projections, EBITDA forecasts, and unit economics that prove substantially inaccurate after the merger closes. Forward-looking statements are sometimes protected by the PSLRA's safe harbor, but the safe harbor requires meaningful cautionary language identifying the specific factors that could cause actual results to differ materially. Boilerplate cautionary language that does not specifically identify the actual risks facing the target company does not satisfy the safe harbor standard. SPAC targets and sponsors who are preparing financial projections for a proxy statement should immediately engage securities fraud counsel to evaluate the basis for each projection and assess the availability of the PSLRA safe harbor.

Material misrepresentation claims allege that a specific statement in a SPAC disclosure document was false when made, while material omission claims allege that known information important to a reasonable investor was left out. Common SPAC misrepresentation claims involve inflated revenue projections, undisclosed regulatory investigations, false statements about the target company's competitive position, and concealed conflicts of interest. Common omission claims involve undisclosed liabilities at the target company, known customer losses, or regulatory inquiries that were pending at the time of the proxy statement but not disclosed. Investors who believe they suffered losses due to a material misrepresentation or omission in a SPAC disclosure document should immediately engage securities fraud class action counsel to evaluate the strength of their claims.

The PSLRA's safe harbor protects certain forward-looking statements from liability in private securities class actions if accompanied by meaningful cautionary language or if the plaintiff cannot prove actual knowledge of falsity. Courts have held that the safe harbor does not protect statements of historical fact, statements accompanied by boilerplate cautionary language, or statements made with actual knowledge of falsity. The SEC has taken the position that the PSLRA safe harbor does not apply in SEC enforcement proceedings, so projections protected in private litigation may still form the basis of an SEC enforcement action. Companies and sponsors facing a SPAC class action that involves forward-looking statement claims should immediately engage class action litigation counsel to evaluate the availability of the PSLRA safe harbor.

The SEC has brought enforcement actions against SPAC sponsors, target companies, and underwriters for disclosure violations in de-SPAC transactions. Common enforcement theories include material misrepresentations in the proxy statement or S-4 registration statement, failure to disclose conflicts of interest, and false or misleading financial projections presented to investors. SEC enforcement actions can result in civil monetary penalties, disgorgement of profits obtained through the misleading disclosure, and officer and director bars that prevent individual defendants from serving as officers or directors of public companies. Companies and individuals who have received an SEC inquiry regarding SPAC disclosures should immediately engage SEC enforcement counsel to assess the scope of potential liability and develop a strategic response.

Directors and officers who signed the SPAC's S-1 or the de-SPAC proxy statement face personal liability under Rule 10b-5 for fraudulent misstatements and under Section 11 of the Securities Act of 1933 for any material misstatement or omission. Section 11 imposes strict liability, meaning the plaintiff does not need to prove that the director or officer knew the statement was false. SPAC D&O policies frequently exclude coverage for claims arising from the de-SPAC merger itself, and coverage gaps can leave individual defendants personally exposed. Directors and officers who are concerned about their personal exposure for SPAC disclosure failures should immediately engage D&O and professional liability counsel to assess the scope of their liability and evaluate the adequacy of their D&O coverage.